Orthobiologics

AlloSource launched AlloFuse® Select CM cellular allograft for use in spinal, orthopaedic and neurologic procedures. ...

Anika Therapeutics received regulatory approval in India for MONOVISC® viscosupplement to treat OA pain in all synovial joints....

A 6-year, randomized clinical trial is underway to evaluate use of a patient’s own stem cells to regenerate knee cartilage....

Histogenics completes enrollment of 245 patients in its NeoCart Phase III clinical trial....

ChoiceSpine launched a biologics portfolio, adding allograft, synthetic bone graft and amnion offerings to complement its spinal hardware portfolio....

Bone Therapeutics received notice that the European Patent Office will grant the company a patent covering its allogeneic cell therapy...

Carmell Therapeutics was issued Canada Patent No. 2,701,187, addressing Methods and Apparatus for Manufacturing Plasma Based Plastics....

Creative Medical filed two patent applications regarding use of immune system cells to stimulate blood vessel formation for the treatment of lower...

Extremity Medical launched BioFuse, a next-gen viable cell bone graft for use in the foot, ankle, wrist and hand....

Bone Therapeutics completed patient recruitment for interim analysis in its Phase III trial of PREOB® for the treatment of hip...